Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Change in nonhigh-density lipoprotein cholesterol levels in adults with prediabetes.

Liu JR, Liu BW, Yin FZ.

Medicine (Baltimore). 2017 Nov;96(44):e8461. doi: 10.1097/MD.0000000000008461.

2.

Statin Therapy Prescribing for Patients with Type 2 Diabetes Mellitus: A Review of Current Evidence and Challenges.

Elnaem MH, Mohamed MHN, Huri HZ, Azarisman SM, Elkalmi RM.

J Pharm Bioallied Sci. 2017 Apr-Jun;9(2):80-87. doi: 10.4103/jpbs.JPBS_30_17. Review.

3.

A new look at risk patterns related to coronary heart disease incidence using survival tree analysis: 12 Years Longitudinal Study.

Ramezankhani A, Bagherzadeh-Khiabani F, Khalili D, Azizi F, Hadaegh F.

Sci Rep. 2017 Jun 12;7(1):3237. doi: 10.1038/s41598-017-03577-0.

4.

Prevalence and pattern of dyslipidemia in Nepalese individuals with type 2 diabetes.

Pokharel DR, Khadka D, Sigdel M, Yadav NK, Acharya S, Kafle R, Sapkota RM, Sigdel T.

BMC Res Notes. 2017 Apr 4;10(1):146. doi: 10.1186/s13104-017-2465-4.

5.

Relationship between non-high-density lipoprotein cholesterol and carotid atherosclerosis in normotensive and euglycemic Chinese middle-aged and elderly adults.

Ma H, Lin H, Hu Y, Li X, He W, Jin X, Gao J, Zhao N, Pan B, Gao X.

Lipids Health Dis. 2017 Mar 16;16(1):55. doi: 10.1186/s12944-017-0451-4.

6.

Impact of postprandial hyperglycemia at clinic visits on the incidence of cardiovascular events and all-cause mortality in patients with type 2 diabetes.

Takao T, Suka M, Yanagisawa H, Iwamoto Y.

J Diabetes Investig. 2017 Jul;8(4):600-608. doi: 10.1111/jdi.12610. Epub 2017 Jan 24.

7.

Association of Serum Apolipoprotein B with the Increased Risk of Diabetes in Korean Men.

Lim HH, Kim OY.

Clin Nutr Res. 2016 Jul;5(3):204-12. doi: 10.7762/cnr.2016.5.3.204. Epub 2016 Jul 29.

8.

Associations between non-traditional lipid measures and risk for type 2 diabetes mellitus in a Chinese community population: a cross-sectional study.

Song Q, Liu X, Wang A, Wang Y, Zhou Y, Zhou W, Wang X.

Lipids Health Dis. 2016 Apr 5;15:70. doi: 10.1186/s12944-016-0239-y.

9.

Low HDL cholesterol as a cardiovascular risk factor in rural, urban, and rural-urban migrants: PERU MIGRANT cohort study.

Lazo-Porras M, Bernabe-Ortiz A, Málaga G, Gilman RH, Acuña-Villaorduña A, Cardenas-Montero D, Smeeth L, Miranda JJ.

Atherosclerosis. 2016 Mar;246:36-43. doi: 10.1016/j.atherosclerosis.2015.12.039. Epub 2015 Dec 29.

10.

The combined effect of visit-to-visit variability in HbA1c and systolic blood pressure on the incidence of cardiovascular events in patients with type 2 diabetes.

Takao T, Matsuyama Y, Suka M, Yanagisawa H, Iwamoto Y.

BMJ Open Diabetes Res Care. 2015 Nov 13;3(1):e000129. doi: 10.1136/bmjdrc-2015-000129. eCollection 2015.

11.

Flaxseed oil intake reduces serum small dense low-density lipoprotein concentrations in Japanese men: a randomized, double blind, crossover study.

Kawakami Y, Yamanaka-Okumura H, Naniwa-Kuroki Y, Sakuma M, Taketani Y, Takeda E.

Nutr J. 2015 Apr 21;14:39. doi: 10.1186/s12937-015-0023-2.

12.

Racial disparities in cardiovascular risk factor control in an underinsured population with Type 2 diabetes.

Wang Y, Katzmarzyk PT, Horswell R, Zhao W, Li W, Johnson J, Ryan DH, Hu G.

Diabet Med. 2014 Oct;31(10):1230-6. doi: 10.1111/dme.12470. Epub 2014 Apr 30.

13.

Reduced risk for metabolic syndrome and insulin resistance associated with ovo-lacto-vegetarian behavior in female Buddhists: a case-control study.

Chiang JK, Lin YL, Chen CL, Ouyang CM, Wu YT, Chi YC, Huang KC, Yang WS.

PLoS One. 2013 Aug 9;8(8):e71799. doi: 10.1371/journal.pone.0071799. eCollection 2013.

14.

Impact of low-density lipoprotein cholesterol on cardiovascular outcomes in people with type 2 diabetes: a meta-analysis of prospective cohort studies.

Wang Y, Lammi-Keefe CJ, Hou L, Hu G.

Diabetes Res Clin Pract. 2013 Oct;102(1):65-75. doi: 10.1016/j.diabres.2013.07.009. Epub 2013 Aug 9.

16.
17.

Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study.

Sone H, Tanaka S, Tanaka S, Iimuro S, Ishibashi S, Oikawa S, Shimano H, Katayama S, Ohashi Y, Akanuma Y, Yamada N; Japan Diabetes Complications Study Group.

Diabetes Care. 2012 May;35(5):1150-7. doi: 10.2337/dc11-1412. Epub 2012 Feb 14.

18.

Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges.

Sampson UK, Fazio S, Linton MF.

Curr Atheroscler Rep. 2012 Feb;14(1):1-10. doi: 10.1007/s11883-011-0219-7. Review.

19.

Supplemental Content

Support Center